Interleukin-HP1-related hybridoma and plasmacytoma growth factors induced by lipopolysaccharide in vivo

Eur J Immunol. 1987 Aug;17(8):1217-20. doi: 10.1002/eji.1830170821.

Abstract

Serum of lipopolysaccharide (LPS)-treated mice was found to support the growth of interleukin-HP1 (HP1)-dependent hybridoma and plasmacytoma cell lines. This growth-promoting activity, which was undetectable in normal serum, rose more than 1000-fold within 2 h after i.v. injection of the toxin and disappeared in less than 1 day. It could be traced to a single component, which behaved like HP1 in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and reverse phase high performance liquid chromatography, and was completely inhibited by a rabbit anti-HP1 antiserum. The LPS-induced factor was apparently not of T cell origin, as indicated by the strong activity found in the serum of LPS-treated nude mice. In vitro, LPS also considerably enhanced the production by macrophages of a factor with similar characteristics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chromatography, High Pressure Liquid
  • Growth Substances / isolation & purification
  • Growth Substances / physiology*
  • Hybridomas / pathology*
  • Immunologic Techniques
  • Interleukin-6
  • Lipopolysaccharides / immunology*
  • Lymphokines / analysis
  • Lymphokines / physiology*
  • Macrophages / physiology
  • Mice
  • Mice, Nude / physiology
  • Monokines
  • Plasmacytoma / pathology*
  • Proteins / physiology

Substances

  • Growth Substances
  • Interleukin-6
  • Lipopolysaccharides
  • Lymphokines
  • Monokines
  • Proteins